Surveillance decision

Surveillance decision

We will transfer the guideline to the static list because:

  • No evidence was identified that would impact on the current guidance and no major ongoing research has been identified as due to be published in the near future (that is, within the next 3–5 years).

  • We will consider integrating this guideline into other related NICE guidelines on acute coronary syndromes in the future.

Reason for the decision

We found 12 new studies through surveillance of this guideline.

This included new evidence on metabolic management of acute coronary syndromes (ACS) and hyperglycaemia in patients with a diagnosis of diabetes and patients without a previous diagnosis of diabetes that supports current recommendations. We also found new evidence on risk factors associated with diabetes in patients with hyperglycaemia. None of the new evidence was thought to have an effect on current recommendations. We asked topic experts whether the new evidence would affect current recommendations on hyperglycaemia in acute coronary syndromes. Generally, the topic experts thought that an update was not needed.

We did not find any new evidence on information that patients with ACS and hyperglycaemia (who are at high risk for developing diabetes) should be provided.

None of the new evidence considered in surveillance of this guideline was thought to have an effect on current recommendations.

In addition, no major ongoing studies or research due to be published in the next 3–5 years was identified.

Other related NICE guidelines on acute coronary syndromes were identified through surveillance into which this guideline can be integrated.

Equalities

No equalities issues were identified during the surveillance process.

Overall decision

After considering all the new evidence and views of topic experts, we decided not to update this guideline and transfer to the static list.

We will consider integrating this guideline into other related NICE guidelines on acute coronary syndromes in the future.

See how we made the decision for further information.


This page was last updated: 08 July 2016